Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor Receptor Gene Mutation in Patients with Non-Small Cell Lung Cancer

Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor... Detection of common EGFR mutations seems to be useful for selecting patients with NSCLC who would likely benefit from gefitinib monotherapy. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor Receptor Gene Mutation in Patients with Non-Small Cell Lung Cancer

Hida, Toyoaki
Journal of Thoracic Oncology , Volume 2 (1) – Jan 1, 2007
Download PDF
7 pages

Loading next page...
 
/lp/wolters-kluwer-health/prospective-validation-for-prediction-of-gefitinib-sensitivity-by-lqB8xsVv1t

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1556-0864

Abstract

Detection of common EGFR mutations seems to be useful for selecting patients with NSCLC who would likely benefit from gefitinib monotherapy.

Journal

Journal of Thoracic Oncology – Wolters Kluwer Health

Published: Jan 1, 2007

There are no references for this article.